Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy
European Journal of Neurology · 2024
DOI: 10.1111/ene.16192 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Panoraia Baka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Hauptthemen laut MEDLINE: Small Fiber Neuropathy, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background and purpose Diagnosing small fiber neuropathies can be challenging. To address this issue, whether serum neurofilament light chain (sNfL) could serve as a potential biomarker of damage to epidermal Aδ‐ and C‐fibers was tested.
Methods
Serum NfL levels were assessed in 30 patients diagnosed with small fiber neuropathy and were compared to a control group of 19 healthy individuals. Electrophysiological studies, quantitative sensory testing and quantification of intraepidermal nerve fiber density after skin biopsy were performed in both the proximal and distal leg.
Results
Serum NfL levels were not increased in patients with small fiber neuropathy compared to healthy controls (9.1 ± 3.9 and 9.4 ± 3.8, p = 0.83) and did not correlate with intraepidermal nerve fiber density at the lateral calf or lateral thigh or with other parameters of small fiber impairment.
Conclusion
Serum NfL levels cannot serve as a biomarker for small fiber damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Neurology, University Hospital of Würzburg, Würzburg, Germany.
- Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.
ORCID-Profile: Panoraia Baka
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Baka, P., Steenken, L., Escolano-Lozano, F., Steffen, F., Papagianni, A., Sommer, C., Pogatzki-Zahn, E., Hirsch, S., Protopapa, M., Bittner, S., & Birklein, F. (2024). Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. European Journal of Neurology. https://doi.org/10.1111/ene.16192
Vancouver
Baka P, Steenken L, Escolano-Lozano F, Steffen F, Papagianni A, Sommer C, et al. Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy. European Journal of Neurology. 2024. doi:10.1111/ene.16192
BibTeX
@article{Baka2024,
author = {Baka, Panoraia and Steenken, Livia and Escolano-Lozano, Fabiola and Steffen, Falk and Papagianni, Aikaterini and Sommer, Claudia and Pogatzki-Zahn, Esther and Hirsch, Silke and Protopapa, Maria and Bittner, Stefan and Birklein, Frank},
title = {Studying serum neurofilament light chain levels as a potential new biomarker for small fiber neuropathy},
journal = {European Journal of Neurology},
year = {2024},
doi = {10.1111/ene.16192}
}
EUVIMED